Results 11 to 20 of about 188 (130)
Contemporary Clinical Dentistry, 2019 Langerhans cell histiocytosis (LCH) is a rare hematological disorder characterized by local or generalized, uncontrolled proliferation and infiltration of Langerhans type of histiocytic cells.
Richa Nangalia +3 more
doaj +1 more source
Giant Cell Lesion or Langerhans' Cell Histiocytosis of the Mandible? A Case Report
European Journal of Inflammation, 2012 Langerhans' cell histiocytosis (LCH), formerly known as histiocytosis X, is characterized by cell proliferation. The leading clinical symptom of LCH within mandibular and maxillary bones is pain and it may resemble periodontal diseases, apical cysts ...
V. Valentini +6 more
doaj +1 more source
Disseminated Langerhans Cell Histiocytosis Presenting as Cholestatic Jaundice [PDF]
Journal of Clinical and Diagnostic Research, 2015 Langerhans cell histiocytosis (LCH) is a disorder associated with proliferation of Langerhans cells in various organs. LCH secondary to multisystem involvement can present in a variety of ways.
Rohit Kapoor +3 more
doaj +1 more source
Clinical Case Reports, 2020 Langerhans cell histiocytosis (LCH) is a benign disease that behaves malignantly. Early recognition and treatment of oral manifestation of LCH by pediatric dentist and other medical specialties is important to prevent further organ damage.
Eman Hussein Hammouri +3 more
doaj +1 more source
Langerhans cell histiocytosis (histiocytosis X) [PDF]
Postgraduate Medical Journal, 1997 Summary There has been a renewed interest in Langerhans cell histiocytosis in recent years due both to advances in basic research and to improvements in diagnostic and treatment approaches. In this article, we review the various aspects of the disease and the potential implications of these recent scientific researches for our ...
openaire +3 more sources
Cutaneous Rosai‐Dorfman Disease With MAP2K1 Mutation Treated With Encorafenib and Binimetinib
JEADV Clinical Practice, EarlyView.ABSTRACT Rosai‐Dorfman disease (RDD) is a rare histiocytic disorder with unifocal to multisystemic involvement. Activating mutations in the MAPK/ERK pathway can occur in up to 50% of RDD cases. We report a case of cutaneous RDD (C‐RDD) with facial and truncal lesions harboring an activating MAP2K1 (MEK1) mutation that showed a complete response to a ...
Melike Ak +2 more
wiley +1 more source
Langerhans cell histiocytosis presented as bilateral otitis media with effusion, a rare case report
Caspian Journal of Internal Medicine, 2023 Background: Langerhans cell histiocytosis (LCH) or histiocytosis X is considered as a rare disease that may have effect on multiple organs. The initial presentation of LCH is varied. The signs and symptoms of otologic histiocytosis can be the same as the
Soheil Motamed +2 more
doaj
Journal of Clinical Periodontology, EarlyView.ABSTRACT Aims This systematic review assesses current evidence on the management of non‐plaque (dental biofilm)‐induced gingival diseases and conditions (NPIGDs), including (i) inflammatory and immune conditions, (ii) neoplasms and (iii) gingival pigmentations.
Maria Clotilde Carra +5 more
wiley +1 more source
Pediatric Dermatology, EarlyView.ABSTRACT Langerhans cell histiocytosis (LCH) is a neoplastic process originating from immature myeloid precursor cells. In this report, we describe a case of a 17‐month‐old with scaling of the scalp and swelling of the bilateral parotid glands who developed acute respiratory distress.
Aretha On +4 more
wiley +1 more source
Oral manifestion of Langerhans cell histiocytosis mimicking inflammation
Indian Journal of Dental Research, 2014 Langerhans cell histiocytosis (LCH) is a rare idiopathic disease characterized by the clonal proliferation of Langerhans cells. LCH affects five children per million population. The peak incidence is from 1 to 4 years of age.
K S Divya
doaj +1 more source